Antiviral drug remdesivir shows mixed results in treating Covid-19 patients

• No significant benefits seen in Chinese clinical trial but researchers say sample size was smaller than targeted
• US government-led study meanwhile finds patients with ‘advanced’ symptoms recovered faster than those given placebo